Trial Profile
Efficacy and cost-benefit analysis of branded versus generic tacrolimus, administered in combination with mycophenolate mofetil + prednisone, in renal transplant recipients in the USA
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2011
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Mycophenolate mofetil; Prednisone
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 10 May 2011 New trial record
- 04 May 2011 Results presented at the American Transplant Congress -- 11th Joint Congress of the American Society of Transplant Surgeons and the American Society of Transplantation.